Streetbeat News

Revenues

BEAM

In the last three months, 4 analysts have updated their ratings on Beam Therapeutics (NASDAQ:BEAM), showing a shift towards a more positive outlook with an average 12-month price target of $43.5, reflecting a 43.42% increase from the previous average of $30.33. The company has shown significant financial growth, with a revenue increase of 1478.04% as of December 31, 2023, and outperforms industry averages in net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:01 pm

BGNE

Four analysts have recently updated their ratings on BeiGene (NASDAQ:BGNE), showing a mix of bullish to indifferent sentiments. The average 12-month price target is now $219.25, down from $243.33, with ratings adjustments reflecting changes in market conditions and company performance. BeiGene, a biotech firm focused on cancer treatment drugs, has shown a significant revenue growth rate of 66.91% as of December 31, 2023, but struggles with profitability and efficiency metrics like net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:00 pm

BK

Bank of New York Mellon (NYSE:BK) has seen varied analyst ratings over the last three months, with a shift towards a more neutral stance in the last 30 days. The average 12-month price target has been raised to $61.75, indicating a bullish outlook from analysts. Key analysts from RBC Capital, Citigroup, Morgan Stanley, and UBS have updated their ratings and price targets, reflecting changes in market conditions and company performance. Despite this, BNY Mellon faces challenges in revenue growth, net margin, ROE, and ROA, compared to industry averages.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:00 pm

TPR

Analyst evaluations of Tapestry (NYSE:TPR) over the last three months show diverse outlooks, with a recent trend towards bullish sentiment. The average 12-month price target for TPR is now $50.6, reflecting a 15.0% increase from the previous target. Tapestry's financial performance is strong, with notable revenue growth, net margin, ROE, and ROA, despite a high debt-to-equity ratio. The company's acquisition of Capri, including brands like Michael Kors, Versace, and Jimmy Choo, could further impact its market position.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:00 pm

GXO

GXO Logistics (NYSE:GXO) has been reviewed by 4 analysts in the last three months, showing a mix of bullish to indifferent sentiments. The average 12-month price target is now $66.00, down from $69.33, with a high of $75.00 and a low of $50.00. Analyst actions include ratings adjustments and price target changes, reflecting the company's market performance and future outlook. GXO's financial performance is strong, with notable revenue growth, high net margin, and efficient asset management, despite a market capitalization below industry average.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:00 pm

MNMD

In a Benzinga Psychedelics Podcast episode, Mind Medicine (MindMed) CEO Robert Barrow discussed the company's progress in developing LSD-based therapy, particularly MM-120 for Generalized Anxiety Disorder. MindMed, which recently received a 'breakthrough therapy' designation from the FDA for this treatment, is advancing clinical trials into Phase 3. Barrow highlighted LSD's potential for deeper therapeutic introspection compared to other psychedelics, attributing its historical research neglect to political rather than scientific reasons.

Portfolio Pulse from Lara Goldstein

March 27, 2024 | 2:25 pm

AAPL

AMD

INTC

SMH

SOXX

TSM

Taiwan Semiconductor Manufacturing Co (TSMC) is experiencing a surge in orders for its 3nm chips from major clients including Apple, Intel, and AMD. The demand for these chips is expected to push TSMC's revenue share from 3nm chips to over 20% this year. The chips are crucial for upcoming products like the iPhone 16 and new Mac processors, Intel's Lunar Lake CPUs, and AMD's Zen 5 architecture platform. Despite challenges in expanding its U.S. operations due to construction delays, TSMC plans to build factories for 2nm chips in Taiwan and is considering a second facility in Japan. TSMC's stock has risen over 53% in the last 12 months, and investors can gain exposure through the VanEck Semiconductor ETF (SMH) and iShares Semiconductor ETF (SOXX).

Portfolio Pulse from Anusuya Lahiri

March 27, 2024 | 2:20 pm

THC

Nine analysts have recently updated their ratings on Tenet Healthcare (NYSE:THC), showing a mix of bullish and somewhat bullish perspectives with no bearish views. The average 12-month price target for THC has been raised to $108.0, up 13.48% from the previous target of $95.17. Analyst actions include maintaining, raising, and announcing ratings with price targets ranging from $100.00 to $122.00. Tenet Healthcare, a Dallas-based healthcare services organization, has shown solid revenue growth and profitability but faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

LEVI

Levi Strauss (NYSE:LEVI) has received mixed analyst ratings over the past three months, with a shift towards a more bullish outlook in the last 30 days. The average 12-month price target for LEVI has increased to $18.83, up from $17.80, indicating a positive sentiment shift among analysts. Key financial indicators such as market capitalization, revenue growth, net margin, ROE, and ROA show Levi Strauss outperforming industry averages, suggesting a strong financial health and efficient management.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

WDC

Recent analyst ratings for Western Digital (NASDAQ:WDC) show a predominantly bullish to neutral sentiment, with an average 12-month price target of $67.21, indicating a 22.2% increase from the previous target. The company faces challenges in revenue growth and operational efficiency, with a -2.41% revenue decline and below-average ROE and ROA. However, its net margin outperforms industry averages. Western Digital, a key player in data storage solutions, competes closely with Seagate in HDDs and leads in NAND flash chips production for SSDs.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:00 pm